"/> Novus Biologicals™ Peptide bloquant d’anticorps EF… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps EFCAB4B

Réf. : BL-RE-050191Réf. fabricant : 18249285 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
84766
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76493. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 14 amino acids near the carboxy terminus of human EFCAB4B.

Points forts

Source

Synthetic

(Accession #: NP_116069) The EFCAB4B Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-050191
Réf. fabricant18249285
Gene ID (Entrez)84766
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76493. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCalcium release-activated calcium channel regulator 2 A, CRAC channel regulator 2 A, CRACR2A, DKFZp686G13246, EF-hand calcium binding domain 4 B, EF-hand calcium-binding domain-containing protein 4 B, FLJ33046, FLJ33805, MGC4266
Symbole de gène(s)CRACR2A
Type de produitEFCAB4B
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne14 amino acids near the carboxy terminus of human EFCAB4B
Une question, une configuration particulière ?
Contactez-nous pour un devis.